CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 655969-656313 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T45894","span":{"begin":0,"end":344},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations have led us to believe that the combination of a cysteinyl leukotriene receptor antagonist Montelukast with an oral antibiotic may be more efficacious than monotherapy with an oral antibiotic in the treatment of serous otitis media."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1097","span":{"begin":0,"end":344},"obj":"Epistemic_statement"}],"text":"Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations have led us to believe that the combination of a cysteinyl leukotriene receptor antagonist Montelukast with an oral antibiotic may be more efficacious than monotherapy with an oral antibiotic in the treatment of serous otitis media."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T215","span":{"begin":0,"end":344},"obj":"Sentence"}],"text":"Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations have led us to believe that the combination of a cysteinyl leukotriene receptor antagonist Montelukast with an oral antibiotic may be more efficacious than monotherapy with an oral antibiotic in the treatment of serous otitis media."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6060","span":{"begin":14,"end":26},"obj":"Disease"},{"id":"T6061","span":{"begin":62,"end":88},"obj":"Disease"},{"id":"T6063","span":{"begin":62,"end":74},"obj":"Disease"},{"id":"T6064","span":{"begin":62,"end":68},"obj":"Disease"},{"id":"T6065","span":{"begin":324,"end":343},"obj":"Disease"},{"id":"T6066","span":{"begin":331,"end":343},"obj":"Disease"},{"id":"T6067","span":{"begin":331,"end":337},"obj":"Disease"}],"attributes":[{"id":"A6060","pred":"mondo_id","subj":"T6060","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A6061","pred":"mondo_id","subj":"T6061","obj":"http://purl.obolibrary.org/obo/MONDO_0005892"},{"id":"A6062","pred":"mondo_id","subj":"T6061","obj":"http://purl.obolibrary.org/obo/MONDO_0021203"},{"id":"A6063","pred":"mondo_id","subj":"T6063","obj":"http://purl.obolibrary.org/obo/MONDO_0024330"},{"id":"A6064","pred":"mondo_id","subj":"T6064","obj":"http://purl.obolibrary.org/obo/MONDO_0021666"},{"id":"A6065","pred":"mondo_id","subj":"T6065","obj":"http://purl.obolibrary.org/obo/MONDO_0021203"},{"id":"A6066","pred":"mondo_id","subj":"T6066","obj":"http://purl.obolibrary.org/obo/MONDO_0024330"},{"id":"A6067","pred":"mondo_id","subj":"T6067","obj":"http://purl.obolibrary.org/obo/MONDO_0021666"}],"text":"Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations have led us to believe that the combination of a cysteinyl leukotriene receptor antagonist Montelukast with an oral antibiotic may be more efficacious than monotherapy with an oral antibiotic in the treatment of serous otitis media."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T3246","span":{"begin":62,"end":88},"obj":"Phenotype"},{"id":"T3247","span":{"begin":331,"end":343},"obj":"Phenotype"}],"attributes":[{"id":"A3246","pred":"hp_id","subj":"T3246","obj":"http://purl.obolibrary.org/obo/HP_0031353"},{"id":"A3247","pred":"hp_id","subj":"T3247","obj":"http://purl.obolibrary.org/obo/HP_0000388"}],"text":"Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations have led us to believe that the combination of a cysteinyl leukotriene receptor antagonist Montelukast with an oral antibiotic may be more efficacious than monotherapy with an oral antibiotic in the treatment of serous otitis media."}